CHLORTHALIDONE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 7 adverse event reports in the FDA FAERS database where CHLORTHALIDONE was used for Psoriasis.
Most Reported Side Effects for CHLORTHALIDONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hyponatraemia | 258 | 15.0% | 20 | 197 |
| Drug ineffective | 209 | 12.1% | 3 | 111 |
| Nausea | 159 | 9.2% | 3 | 113 |
| Hypokalaemia | 136 | 7.9% | 0 | 96 |
| Dizziness | 133 | 7.7% | 0 | 81 |
| Acute kidney injury | 126 | 7.3% | 20 | 103 |
| Oedema peripheral | 114 | 6.6% | 1 | 94 |
| Vomiting | 107 | 6.2% | 2 | 91 |
| Hypotension | 102 | 5.9% | 24 | 78 |
| Dyspnoea | 96 | 5.6% | 4 | 69 |
| Hypertension | 84 | 4.9% | 0 | 37 |
| Headache | 83 | 4.8% | 0 | 48 |
| Presyncope | 79 | 4.6% | 0 | 79 |
| Fatigue | 77 | 4.5% | 5 | 34 |
| Asthenia | 75 | 4.4% | 2 | 39 |
Other Indications for CHLORTHALIDONE
Product used for unknown indication (656)
Hypertension (599)
Blood pressure abnormal (30)
Blood pressure measurement (28)
Cardiac failure (25)
Diuretic therapy (23)
Blood pressure increased (10)
Obesity (9)
Cardiac failure congestive (8)
Fluid retention (8)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)